ITPKB and head and neck squamous cell carcinoma: Consistent with this, the authors reported that expression of ITPKB and cisplatin resistance positively correlated in 22 human cancer cell lines and 13 patient-derived xenograft tumours of head and neck squamous cell carcinoma (HNSCC), lung cancer and ovarian cancer.